Clinical Trials Logo

Clinical Trial Summary

An open-label, single center, three-arm observational study to examine emissions from e-cigarettes versus conventional cigarettes under three environmental settings of typical residential, office and hospitality facilities.


Clinical Trial Description

Specific constituents will be measured in exhaled breath samples (EBS) from adult e-vapor product users and smokers when they are using e-vapor products or smoking conventional cigarettes. These constituents and particle counts (PC), will be measured in the room air samples (RAS) collected in the environmental exposure chamber (EEC) where adult e-cigarette users and smokers are using electronic cigarettes or smoking conventional cigarettes. All subjects will undergo a Screening Visit to assess if they meet study eligibility criteria. If all eligibility criteria are met and the subject signs informed consent, the subject will be assigned to one of three groups: Group I (JUUL), Group II (VUSE Solo), or Group III (Conventional Cigarettes). All three Groups will be sequentially observed in environmental settings 1 (residential), 2 (office), and 3 (hospitality). The observation period allocated for each environmental setting will be 2-days and 2-overnights for Groups I and II, and 1-day and 1-overnight for Group III. Each observation period will be referred to as a "Clinic Visit". Subjects will move on to subsequent Environment Settings (Clinic Visits 2 or 3) after completion of the previous Clinic Visit (1 or 2). Subjects must return to the clinic for Clinic Visit 1 within 60 days of the Screening Visit. Clinic Visit 2 must occur 7 ± 2 days after the Clinic Visit 1, and Clinic Visit 3 must occur 7 ± 2 days after Clinic Visit 2. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03605641
Study type Interventional
Source Juul Labs, Inc.
Contact
Status Completed
Phase N/A
Start date September 17, 2018
Completion date December 2, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03102684 - Impact of Secondhand Exposure to E-cigarettes Aerosols on the Respiratory System N/A
Completed NCT02557919 - Families Reduce Exposure to Smoke at Home N/A
Enrolling by invitation NCT06042361 - Enhancing Equity in Smoke-free Housing N/A
Completed NCT03151421 - Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home N/A
Completed NCT04791722 - Optimizing Smoke-free Residential Housing Policies N/A
Completed NCT01745393 - Kids Safe and Smokefree (KiSS) N/A
Completed NCT03567512 - Reducing Second-hand Smoke Exposure Among Young Children in Rural China N/A
Completed NCT03074734 - Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 ) N/A
Completed NCT01228916 - Community-Partnered Dominican Republic Tobacco Control N/A
Completed NCT01921439 - OCAST Cessation Study N/A
Active, not recruiting NCT04974736 - eCEASE to Support Treatment for Parental Tobacco Use N/A
Not yet recruiting NCT06166433 - Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia N/A
Recruiting NCT04855357 - Smoke-free Home Intervention in Permanent Supportive Housing N/A
Completed NCT03476837 - Reducing Tobacco Exposures Among African American Women and Children N/A
Recruiting NCT06127589 - The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure N/A
Active, not recruiting NCT05366790 - A Brief Digital Screening Tool to Address Tobacco and E-cigarette Use in Pediatric Medical Care N/A
Completed NCT02602288 - Babies Living Safe and Smokefree N/A
Active, not recruiting NCT03150186 - Environmental Assessment of Secondhand Smoke Exposure in Private Settings and Outdoor Settings in Europe N/A
Completed NCT02928536 - The TackSHS Survey: a Pan-European Study on SHS
Completed NCT02281864 - Interventions to Help Smoking Parents of Inpatients Reduce Exposure (INSPIRE) N/A